Higher expression of the ACE2 gene in visceral and subcutaneous adipose tissue than in lung tissue may exacerbate infection, prolong hospitalization time, and increase the risk of death in obese patients with COVID-19 [121,122,123,124]. This evidence concerns the gene ACE2 and COVID-19.